Survival rates for patients with hepatocellular carcinoma (HCC) have improved, but overall survival remains low. Early detection and treatment significantly enhanced survival outcomes between ...

Key Takeaways The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma, a prevalent and deadly liver cancer in the U.S. CHECKMATE-9DW trial results showed ...

Long-term use of statins may delay or deflect the development of hepatocellular carcinoma in adults with chronic liver disease, as well as in the general population, emerging research, including ...

Hepatocellular carcinoma, also called liver cell carcinoma, is the most common type of liver cancer. It begins in the liver when liver cells become cancerous. Hepatocellular carcinoma (HCC), or ...

Fatty liver disease, now medically known as MASLD, is becoming more common, especially among people who are overweight, ...

What is liver cancer? Expert explains causes, symptoms and how to treat it - Many adults remain unaware of the risk factors ...

Hepatitis C in children is often symptomless but can lead to severe liver disease if undetected. Experts urge early screening ...

Fatty liver is a common condition that is gradually afftecting the entire nation, making people sick due to lifestyle, diet ...

A 59-year-old man with a history of metabolic dysfunction–associated steatotic liver disease had an enlarging liver mass. Biopsy showed hepatocellular carcinoma. Management decisions were made.

Weight loss without diet changes, along with loss of appetite, can be initial warning signs of liver cancer. Your stomach ...